4
Changes in Ownership
Protagenic Therapeutics, Inc.\new Filed Acc 0001437749-17-017235
Options or other derivatives
- Director acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Stein Robert Benjamin Director | 2017-10-16 | Grant or award · Non-Qualified Stock Options (Right to Buy() | +200,000 | 200,000 | D: show line 1 in the form |
Loading xslF345X03/rdgdoc.xml…